4.7 Article

Paxilline enhances TRAIL-mediated apoptosis of glioma cells via modulation of c-FLIP, survivin and DR5

Related references

Note: Only part of the references are listed.
Review Oncology

Anti-apoptosis mechanisms in malignant gliomas

David S. Ziegler et al.

JOURNAL OF CLINICAL ONCOLOGY (2008)

Review Biochemistry & Molecular Biology

Potential biochemical therapy of glioma cancer

Li-Tian Yin et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)

Review Oncology

Calcium and cancer:: targeting Ca2+ transport

Gregory R. Monteith et al.

NATURE REVIEWS CANCER (2007)

Article Biochemistry & Molecular Biology

KCNMA1 gene amplification promotes tumor cell proliferation in human prostate cancer

M. Bloch et al.

ONCOGENE (2007)

Article Pharmacology & Pharmacy

The antiestrogen tamoxifen activates BK channels and stimulates proliferation of MCF-7 breast cancer cells

Guyllaume Coiret et al.

MOLECULAR PHARMACOLOGY (2007)

Article Oncology

Therapeutic advantage of combining calcium channel blockers and TRAIL in prostate cancer

Ismail Kaddour-Djebbar et al.

MOLECULAR CANCER THERAPEUTICS (2006)

Article Cell Biology

Changes in intracellular Ca2+ and pH in response to thapsigargin in human glioblastoma cells and normal astrocytes

GG Kovacs et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2005)

Article Neurosciences

Role for calcium-activated potassium channels (BK) in growth control of human malignant glioma cells

AK Weaver et al.

JOURNAL OF NEUROSCIENCE RESEARCH (2004)

Article Biochemistry & Molecular Biology

The mechanism of inhibition of the sarco/endoplasmic reticulum Ca2+ ATPase by paxilline

JG Bilmen et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2002)

Review Biochemistry & Molecular Biology

The molecular basis and potential role of survivin in cancer diagnosis and therapy

DC Altieri

TRENDS IN MOLECULAR MEDICINE (2001)